Clinical Trials at Texas Children's Hospital
As of September 2026, 99 paid clinical trials are recruiting at Texas Children's Hospital, located at 1 BAYLOR PLZ, BCM 286, N1319, HOUSTON, TX 77030-3411, phone (713) 798-8918 in Houston, Texas. Active studies at this site cover conditions such as Breast Cancer, Acute Myeloid Leukemia and Advanced Solid Tumor. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
Newly added in Houston
Posted to ClinicalTrials.gov within the last 60 days — these studies are just starting to recruit.
100 clinical trials at Texas Children's Hospital
·Clear filters·A Study Investigating Oral Ozanimod (RPC1063) in Pediatric Participants With Moderate to Severe Active Ulcerative Colitis
Registry of Patients With a Diagnosis of Spinal Muscular Atrophy (SMA)
Fontan Udenafil Exercise Longitudinal Assessment Trial - 2
EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Years of Age With COVID-19 That Are Not Hospitalized But Are at Risk for Severe Disease
A Study to Assess the Safety, Tolerability, Efficacy, Pharmacokinetics, and Immunogenicity of Intravenous Administration of ARGX-119 in Pediatric Participants Aged 5 to Less Than 18 Years With Spinal Muscular Atrophy
Phase 2b Study of RPT904 as Monotherapy in Participants With IgE-Mediated Food Allergy
A Study of Pitolisant in Patients With Prader-Willi Syndrome
A Phase 2 Study of Mutant-selective PI3Kα Inhibitor, RLY-2608, in Adults and Children With PIK3CA Related Overgrowth Spectrum and Malformations Driven by PIK3CA Mutation (The ReInspire Study)
Study of an Intrathecal Port and Catheter System for Subjects With Spinal Muscular Atrophy
REVEAL: A Phase 3 Study of Obudanersen (ION582) in Angelman Syndrome
Study of Olutasidenib and Temozolomide in HGG
Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)
Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
A Study of Vedolizumab in Children and Teenagers With Moderate to Severe Crohn's Disease (CD)
52 Week Study + 24-Month Long-Term Extension of Safety, PK, & Efficacy of XYOSTED® for Testosterone Replacement in Male Adolescents With Hypogonadism
Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia
A Study to Evaluate Tovorafenib in Pediatric and Young Adult Participants With Relapsed or Progressive Low-Grade Glioma and Advance Solid Tumors
QUELIMMUNE (SCD-PED) PediAtric SurVeillance REgistry
First-in-human Study of a New Treatment (4A10) for Patients With Relapsed or Hard-to-treat Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma, Focused on Safety and How the Drug Behaves in the Body and Early Signs of Effect.
Danon Disease Natural History Study
AERA Pediatrics Registry
A Feasibility Safety Study of Benign Centrally-Located Intracranial Tumors in Pediatric and Young Adult Subjects
A Study to Assess the Long-term Safety and Clinical Activity of mRNA-3927 in Participants Previously Enrolled in the mRNA-3927-P101 Study
A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
Bowel Continence Across the Lifespan in People With Spina Bifida
Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Electrophysiologic Sleep Phenotyping and Sleep-Dependent Neuro-maturation in Clinical and Healthy Pediatric Populations
Biospecimen Collection to Identify Gene Mutations for High Risk Pancreatic Cancer in Pediatric Patients, INSPPIRE 2 Study
Targeted Pediatric High-Grade Glioma Therapy
ACT001 for the Treatment of Diffuse Intrinsic Pontine Gliomas and H3K27-altered High Grade Gliomas
Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma
Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma
Cord Clamping Among Neonates With Congenital Heart Disease
Humidity in Incubators for Tiny Infants
Treatment of Obstructive Sleep Apnea With Personalized Surgery in Children With Down Syndrome (TOPS-DS)
Trivalent CAR-T Cell in Acute B-Lineage Leukemia (TRICAR-ALL)
Natural History and Biospecimen Acquisition for Children and Adults With Rare Solid Tumors
Neurodevelopmental Outcomes in Children: Strengthening the Caregiver-Child Story
Study of the ITK Inhibitor Soquelitinib to Reduce Lymphoproliferation and Improve Cytopenias in Autoimmune Lymphoproliferative Syndrome (ALPS)-FAS Patients
Common conditions studied in Houston
- Breast Cancer (76 active studies)
- Acute Myeloid Leukemia (54 active studies)
- Advanced Solid Tumor (52 active studies)
- Colorectal Cancer (47 active studies)
- Ovarian Cancer (47 active studies)
- Prostate Cancer (45 active studies)
Leading research sponsors in Houston
- M.D. Anderson Cancer Center
- The University of Texas Health Science Center, Houston
- Baylor College of Medicine
- AstraZeneca
- The Methodist Hospital Research Institute
Frequently asked questions
How many paid clinical trials are currently recruiting in Houston?
There are approximately 3,049 recruiting clinical trials in Houston, Texas listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Houston pay participants?
Most recruiting trials in Houston compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Houston?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Houston?
The most common conditions under active study in Houston include Breast Cancer (76), Acute Myeloid Leukemia (54), Advanced Solid Tumor (52), Colorectal Cancer (47), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Houston?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Houston on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Houston?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Houston?
Recruiting research sites in Houston include MD Anderson Cancer Center, M D Anderson Cancer Center, Baylor College of Medicine, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Houston right now?
The largest active categories in Houston are Cancer & tumors (1,179), Neurology & pain (138), Cardiovascular (105). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.
What is the address of Texas Children's Hospital?
Texas Children's Hospital is located at 1 BAYLOR PLZ, BCM 286, N1319, HOUSTON, TX 77030-3411. Use the Google Maps link in the intro above to get directions.
How do I contact Texas Children's Hospital?
You can reach Texas Children's Hospital by phone at (713) 798-8918. For questions about a specific trial, use the study coordinator contact listed on the individual study record — click any trial title above to open it.